<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Impot Res</journal-id><journal-id journal-id-type="iso-abbrev">Int J Impot Res</journal-id><journal-id journal-id-type="pmc-domain-id">981</journal-id><journal-id journal-id-type="pmc-domain">npgopen</journal-id><journal-title-group><journal-title>International Journal of Impotence Research</journal-title></journal-title-group><issn pub-type="ppub">0955-9930</issn><issn pub-type="epub">1476-5489</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Nature Portfolio</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12474546</article-id><article-id pub-id-type="pmcid-ver">PMC12474546.1</article-id><article-id pub-id-type="pmcaid">12474546</article-id><article-id pub-id-type="pmcaiid">12474546</article-id><article-id pub-id-type="pmid">39934247</article-id><article-id pub-id-type="doi">10.1038/s41443-025-01024-7</article-id><article-id pub-id-type="publisher-id">1024</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Intraoperative frozen section examination for penile cancer surgery: a systematic review</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0001-8427-6092</contrib-id><name name-style="western"><surname>Yunis</surname><given-names initials="MZ">Mohammad Z.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5703-2319</contrib-id><name name-style="western"><surname>Pang</surname><given-names initials="KH">Karl H.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2958-1614</contrib-id><name name-style="western"><surname>Muneer</surname><given-names initials="A">Asif</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6364-0310</contrib-id><name name-style="western"><surname>Alnajjar</surname><given-names initials="HM">Hussain M.</given-names></name><address><email>Hussain.alnajjar@nhs.net</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0220mzb33</institution-id><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution>King&#8217;s College London Medical School, </institution></institution-wrap>London, UK </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/042fqyp44</institution-id><institution-id institution-id-type="GRID">grid.52996.31</institution-id><institution-id institution-id-type="ISNI">0000 0000 8937 2257</institution-id><institution>Institute of Andrology, Department of Urology, </institution><institution>University College London Hospitals NHS Foundation Trust, </institution></institution-wrap>London, UK </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02jx3x895</institution-id><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2190 1201</institution-id><institution>Division of Surgery and Interventional Science, </institution><institution>University College London, </institution></institution-wrap>London, UK </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02jx3x895</institution-id><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2190 1201</institution-id><institution>Department of Surgical Biotechnology, </institution><institution>University College London, </institution></institution-wrap>London, UK </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/042fqyp44</institution-id><institution-id institution-id-type="GRID">grid.52996.31</institution-id><institution-id institution-id-type="ISNI">0000 0000 8937 2257</institution-id><institution>NIHR Biomedical Research Centre, </institution><institution>University College London Hospitals NHS Foundation Trust, </institution></institution-wrap>London, UK </aff></contrib-group><pub-date pub-type="epub"><day>11</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>37</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">497682</issue-id><fpage>721</fpage><lpage>727</lpage><history><date date-type="received"><day>1</day><month>10</month><year>2024</year></date><date date-type="rev-recd"><day>8</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>23</day><month>1</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>11</day><month>02</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>28</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-28 13:25:37.627"><day>28</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="41443_2025_Article_1024.pdf"/><abstract id="Abs1"><p id="Par1">Penile cancer (PeCa) is rare but aggressive and life changing. Penile-preserving surgery (PPS) allows length preservation for sexual activity and normal voiding. Intraoperative frozen section examination (FSE) of resection margins helps to decide on how much penile tissue is excised. Oncological outcomes and diagnostic accuracy of FSE to date, however, are not well documented. The objective of this systematic review was to evaluate the efficacy of FSE in the treatment of PeCa and its impact on oncological outcomes. A systematic review was conducted with reference to the PRISMA statement. Studies published from 2009 to 2024 were identified through a search conducted between 1975 and 2024. The search yielded 7 studies involving 574 patients. Intraoperative FSE had a high percentage of accuracy, with a mean accuracy of 95.4% and a range of 92.9&#8211;99.4%. The mean values of sensitivity, specificity, positive predictive value, and negative predictive values were 71.4%, 99.9%, 98.8%, and 96.5%, respectively. Functional outcomes with PPS were encouraging, especially in terms of sexual function. The average local recurrence rate was 7.9%. There is a paucity of data on PeCa FSE in the literature. However, it appears that FSE is accurate and can be helpful in guiding surgeons intraoperatively when performing PPS.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Urogenital diseases</kwd><kwd>Diagnosis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Penile cancer (PeCa) is rare and commonly occurs in the 6th and 7th decades of life [<xref ref-type="bibr" rid="CR1">1</xref>]. The age-standardised incidence of PeCa was 0.80 per 100,000 men in the world with a total of 37,699 incidences, according to the 2022 Global Cancer Observatory (GLOBOCAN) [<xref ref-type="bibr" rid="CR2">2</xref>]. According to a population-based observational study, the 5-year survival rate of PeCa between 2002 and 2007 is approximately 70%. Verhoeven et al. showed that this figure does not show statistically significant changes in medically advanced countries like in the European Union [<xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par3">Histopathological analysis plays a crucial role in the diagnosis, risk stratification, assessment of depth of invasion and resection margins of PeCa. Squamous cell carcinoma (SCC) accounts for 95% of PeCa with usual type SCC exhibiting the most common subtype [<xref ref-type="bibr" rid="CR4">4</xref>]. Historically, a 20&#8201;mm macroscopic resection margin was required but with the use of intraoperative frozen section examination (FSE), it allows further resection of a positive margin during the same operation and be conservative with macroscopic margins [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Penile-preserving surgery (PPS) preserves penile length, urinary function and sexual function, allowing for standing voiding while reducing psychological impact and avoiding emasculating surgery [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. The European Association of Urology (EAU) and the American Society of Clinical Oncology (ASCO) recommend that standard excision should encompass a margin of clinically normal-appearing skin around the tumour and any surrounding erythema to achieve complete removal with histologically negative margins [<xref ref-type="bibr" rid="CR9">9</xref>].</p><p id="Par4">FSE has an important role in determining margin status intraoperatively however, it is not routinely implemented in diagnostic testing because several lesions have well-differentiated squamous cell growth that can mimic non-neoplastic lesions and conversely some hyperplastic lesions can have a pseudoepitheliomatous appearance [<xref ref-type="bibr" rid="CR10">10</xref>&#8211;<xref ref-type="bibr" rid="CR12">12</xref>]. Patients must be informed of the negative implications of FSE, when there is discordance between FSE and final histology, patients may develop early local recurrence. There is a lack of data on FSE accuracy in the management of PeCa in the literature. In this systematic review, we aim to provide the accuracy of FSE surgical margins and its outcomes in the context of PeCa excisional surgery, alongside a narrative review of the available evidence.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Methods and materials</title><sec id="Sec3"><title>Search strategy</title><p id="Par5">The systematic review was conducted following the PRISMA 2020 reporting guidelines (Supplementary Table&#160;<xref rid="MOESM3" ref-type="media">1</xref>) [<xref ref-type="bibr" rid="CR13">13</xref>], and a search was performed on the 26th of January 2023. An updated search was performed on the 12th of September 2024. The review was registered with PROSPERO (ID: 387370). The search strategy was developed by two investigators (MZY and KHP) and is shown in the Supplementary Table&#160;<xref rid="MOESM1" ref-type="media">2</xref> for each source. The search strategy was written for PubMed but was translated using each database&#8217;s syntax and search fields. Boolean operators &#8220;AND&#8221; and &#8220;OR&#8221; were respectively used to include results with both texts and include results with one or the other.</p><p id="Par6">We searched the following databases: PubMed, Cochrane CENTRAL and OVID (Medline and Embase). The retrieved literature from these databases was scarce, therefore we identified other studies by searching on Google Scholar.</p><p id="Par7">All database records were exported to EndNote 20 where duplication, title, and abstract screening occurred [<xref ref-type="bibr" rid="CR14">14</xref>]. Full-text articles were screened when eligible and reasons for acceptance or rejection were recorded in an Excel spreadsheet (Microsoft Excel version 16).</p></sec><sec id="Sec4"><title>Eligibility criteria</title><p id="Par8">Original articles reporting on men with penile lesions affecting any area of the penis were included, and surgical inclusion criteria were excisional surgery of the lesion with the use of intraoperative FSE for curative intent of the lesion, including PPS, partial and radical penectomy. Studies with insufficient data on the concordance of intraoperative FSE with paraffin histology were excluded. Other exclusion criteria were reviews, case reports, editorials, letters, articles not in English and congress abstracts. The population (P), intervention (I), comparison (C), outcome (O), and studies (S) framework used was:</p><p id="Par9">P: patients with PeCa</p><p id="Par10">I: excisional margin FSE</p><p id="Par11">C: diagnostic paraffin section histology</p><p id="Par12">O: diagnostic testing accuracy (DTA) of FSE (e.g., sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV)), final margin status, sexual and urinary function, survival, recurrence, metastasis and postoperative complications.</p><p id="Par13">S: randomised and non-randomised trials, retrospective or prospective cohort studies and case series.</p></sec><sec id="Sec5"><title>Study selection</title><p id="Par14">After completion of our search, the titles of all studies included in the search were screened. Following this, abstracts were screened in studies with eligible titles which allowed the author to then review all the relevant full-text articles. Two investigators (MZY and KHP) independently reviewed the full-text confirming eligibility for our systematic review.</p></sec><sec id="Sec6"><title>Data extraction &#8211; variables</title><p id="Par15">Extracted variables included study characteristics: author, year of publication, population, adjuvant therapy, and surgery type. For studies which included the pathology data, we looked for FSE margins, final surgical margins, tumour grade, tumour stage, nodal stage, and penile intraepithelial neoplasia (PeIN) or carcinoma in situ (CIS). The primary outcome was the concordance of FSE margins when compared with the final paraffin histology reports. The analysis of the concordance of FSE was done by calculating the DTA: sensitivity, specificity, PPV, NPV. This was done by inputting true positive (TP), false positive (FP), false negative (FN), and true negative (TN) results into MedCalc&#8217;s diagnostic test evaluator tool [<xref ref-type="bibr" rid="CR15">15</xref>]. Accuracy of intraoperative FSE is defined as the probability that a patient is correctly classified: TN being negative margins, and TP being positive margins. For secondary outcomes, we looked at final margin status, sexual and urinary function, survival, recurrence, metastasis, and postoperative complications. A meta-analysis was unable to be performed from the extracted data due to the heterogeneity of available studies, so a descriptive analysis was performed instead.</p></sec><sec id="Sec7"><title>Quality assessment of individual studies</title><p id="Par16">The risk of bias (RoB) of the included studies was assessed using the Newcastle-Ottawa Scale (NOS) for evaluating the quality of non-randomised cohort studies [<xref ref-type="bibr" rid="CR16">16</xref>]. However, we utilised the British Medical Journal&#8217;s revision of the NOS scale specifically for case series due to the predominance of this study design in the included literature [<xref ref-type="bibr" rid="CR17">17</xref>]. We looked at three factors which were considered to assess the quality of each of our 7 studies:<list list-type="order"><list-item><p id="Par17">Selection: exposed cohort representativeness, selection of controls, ascertainment of exposure, and definition of controls</p></list-item><list-item><p id="Par18">Comparability: assessed on the matching of individuals and any other factors</p></list-item><list-item><p id="Par19">Outcome: on assessment method, follow-up time, and adequacy of follow-up</p></list-item></list></p><p id="Par20">Each study was classified as having high, moderate or low methodological quality based on the points achieved, with 7&#8211;9 points deemed high quality, 5&#8211;6 points classified as moderate quality, and fewer than 5 points indicating low methodological quality.</p></sec></sec><sec id="Sec8" sec-type="results"><title>Results</title><sec id="Sec9"><title>Study selection</title><p id="Par21">Figure&#160;<xref rid="Fig1" ref-type="fig">1</xref> describes the study inclusion process in the form of a flow chart following PRISMA (2020) [<xref ref-type="bibr" rid="CR13">13</xref>]. The initial search on the 26th of January 2023 identified 1303 records. Title and abstract screening were performed, after which 24 studies fulfilled the PICOS criteria, which then underwent further evaluation. From these studies, an additional 18 papers were excluded due to insufficient reporting on the details of FSE, and its concordance with final paraffin histology, which rendered them unsuitable for our systematic review. An updated search was performed on the 12th of September 2024 which retrieved 124 papers, 1 of which was included for analysis. Overall, 7 studies were included, and the extracted data are summarised in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>. There were no randomised or non-randomised controlled studies, and all 7 studies included were observational studies. The total number of patients with intraoperative FSE was 574.<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Flow diagram of the search following PRISMA (2020) [<xref ref-type="bibr" rid="CR13">13</xref>].</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e360" position="float" orientation="portrait" xlink:href="41443_2025_1024_Fig1_HTML.jpg"/></fig><table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Studies histopathology and outcomes results.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Study</th><th colspan="1" rowspan="1">FSE (<italic toggle="yes">n</italic>)</th><th colspan="1" rowspan="1">Surgery type (<italic toggle="yes">n</italic>)</th><th colspan="1" rowspan="1">Final surgical margins (<italic toggle="yes">n</italic>)</th><th colspan="1" rowspan="1">Tumour grade (<italic toggle="yes">n</italic>)</th><th colspan="1" rowspan="1">Tumour stage (<italic toggle="yes">n</italic>)</th><th colspan="1" rowspan="1">Time to follow-up (months)</th><th colspan="1" rowspan="1">Complications (<italic toggle="yes">n</italic>)</th><th colspan="1" rowspan="1">Recurrence (<italic toggle="yes">n</italic>)</th></tr></thead><tbody><tr><td rowspan="5" colspan="1">Li et al. [<xref ref-type="bibr" rid="CR18">18</xref>]</td><td rowspan="5" colspan="1">32</td><td colspan="1" rowspan="1">RC (8)</td><td colspan="1" rowspan="1">Negative (32)</td><td colspan="1" rowspan="1">G1 (21)</td><td colspan="1" rowspan="1">pTa (5)</td><td colspan="1" rowspan="1">Mean (N/R)</td><td rowspan="5" colspan="1">3</td><td rowspan="5" colspan="1">3</td></tr><tr><td colspan="1" rowspan="1">WLE (18)</td><td colspan="1" rowspan="1">Positive (0)</td><td colspan="1" rowspan="1">G2 (1)</td><td colspan="1" rowspan="1">pTis (2)</td><td colspan="1" rowspan="1">Median (26.5)</td></tr><tr><td colspan="1" rowspan="1">WLE &amp; CC (6)</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">G3 (3)</td><td colspan="1" rowspan="1">pT1 (23)</td><td colspan="1" rowspan="1">Range (2&#8211;61)</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">G4 (0)</td><td colspan="1" rowspan="1">pT2 (2)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">pT3 (0)</td><td colspan="1" rowspan="1"/></tr><tr><td rowspan="5" colspan="1">Morelli et al. [<xref ref-type="bibr" rid="CR19">19</xref>]</td><td rowspan="5" colspan="1">15</td><td colspan="1" rowspan="1">TG (14)</td><td colspan="1" rowspan="1">Negative (15)</td><td colspan="1" rowspan="1">G1 (6)</td><td colspan="1" rowspan="1">pTa (5)</td><td colspan="1" rowspan="1">Mean (36)</td><td rowspan="5" colspan="1">4</td><td rowspan="5" colspan="1">0</td></tr><tr><td colspan="1" rowspan="1">TG &amp; DC (1)</td><td colspan="1" rowspan="1">Positive (0)</td><td colspan="1" rowspan="1">G2 (8)</td><td colspan="1" rowspan="1">pTis (0)</td><td colspan="1" rowspan="1">Median (N/R)</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">G3 (1)</td><td colspan="1" rowspan="1">pT1 (7)</td><td colspan="1" rowspan="1">Range (10&#8211;67)</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">G4 (0)</td><td colspan="1" rowspan="1">pT2 (4)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">pT3 (2)</td><td colspan="1" rowspan="1"/></tr><tr><td rowspan="4" colspan="1">Danakas et al. [<xref ref-type="bibr" rid="CR20">20</xref>]</td><td rowspan="4" colspan="1">31</td><td colspan="1" rowspan="1">PP (21)</td><td colspan="1" rowspan="1">Negative (27)</td><td colspan="1" rowspan="1">G1 (10)</td><td colspan="1" rowspan="1">pTa &amp; pTis (2)</td><td colspan="1" rowspan="1">Mean (38)</td><td rowspan="4" colspan="1">N/R</td><td rowspan="4" colspan="1">5</td></tr><tr><td colspan="1" rowspan="1">TP (10)</td><td colspan="1" rowspan="1">Positive (4)</td><td colspan="1" rowspan="1">G2 (13)</td><td colspan="1" rowspan="1">pT1 (14)</td><td colspan="1" rowspan="1">Median (27)</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">G3 (8)</td><td colspan="1" rowspan="1">pT2 (7)</td><td colspan="1" rowspan="1">Range (1&#8211;137)</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">G4 (0)</td><td colspan="1" rowspan="1">pT3 (8)</td><td colspan="1" rowspan="1"/></tr><tr><td rowspan="6" colspan="1">Ellul et al. [<xref ref-type="bibr" rid="CR21">21</xref>]</td><td rowspan="6" colspan="1">169</td><td colspan="1" rowspan="1">PP (77)</td><td colspan="1" rowspan="1">Negative (169)</td><td colspan="1" rowspan="1">G1 (22)</td><td colspan="1" rowspan="1">pTa (1)</td><td colspan="1" rowspan="1">Mean (N/R)</td><td rowspan="6" colspan="1">N/R</td><td rowspan="6" colspan="1">9</td></tr><tr><td colspan="1" rowspan="1">GR (8)</td><td colspan="1" rowspan="1">Positive (0)</td><td colspan="1" rowspan="1">G2 (57)</td><td colspan="1" rowspan="1">pTis (7)</td><td colspan="1" rowspan="1">Median (45)</td></tr><tr><td colspan="1" rowspan="1">PG (6)</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">G3 (74)</td><td colspan="1" rowspan="1">pT1 (50)</td><td colspan="1" rowspan="1">Range (6&#8211;170)</td></tr><tr><td colspan="1" rowspan="1">TG (70)</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">G4 (6)</td><td colspan="1" rowspan="1">pT2(70)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">WLE (9)</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">pT3 (38)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">pT4 (1)</td><td colspan="1" rowspan="1"/></tr><tr><td rowspan="2" colspan="1">O&#8217;Kelly et al. [<xref ref-type="bibr" rid="CR22">22</xref>]</td><td rowspan="2" colspan="1">19</td><td rowspan="2" colspan="1">GR (19)</td><td colspan="1" rowspan="1">Negative (18)</td><td rowspan="2" colspan="1">N/R</td><td rowspan="2" colspan="1">N/R</td><td rowspan="2" colspan="1">N/R</td><td rowspan="2" colspan="1">0</td><td rowspan="2" colspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Positive (1)</td></tr><tr><td rowspan="5" colspan="1">Parnham et al. [<xref ref-type="bibr" rid="CR23">23</xref>]</td><td rowspan="5" colspan="1">171</td><td rowspan="5" colspan="1">TG (171)</td><td colspan="1" rowspan="1">Negative (154)</td><td colspan="1" rowspan="1">G1 (7)</td><td colspan="1" rowspan="1">pTa (0)</td><td colspan="1" rowspan="1">Mean (N/R)</td><td rowspan="5" colspan="1">50</td><td rowspan="5" colspan="1">19</td></tr><tr><td colspan="1" rowspan="1">Positive (17)</td><td colspan="1" rowspan="1">G2 (48)</td><td colspan="1" rowspan="1">pTis (0)</td><td colspan="1" rowspan="1">Median (41.4)</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">G3 (117)</td><td colspan="1" rowspan="1">pT1 (56)</td><td colspan="1" rowspan="1">Range (2&#8211;155)</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">G4 (0)</td><td colspan="1" rowspan="1">pT2 (98)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">pT3 (21)</td><td colspan="1" rowspan="1"/></tr><tr><td rowspan="7" colspan="1">Pang and Yunis et al. [<xref ref-type="bibr" rid="CR24">24</xref>]</td><td rowspan="7" colspan="1">137</td><td colspan="1" rowspan="1">GL (72)</td><td colspan="1" rowspan="1">Negative (122)</td><td colspan="1" rowspan="1">G1 (7)</td><td colspan="1" rowspan="1">pTa (0)</td><td colspan="1" rowspan="1">Mean (N/R)</td><td rowspan="5" colspan="1">N/R</td><td rowspan="5" colspan="1">14</td></tr><tr><td colspan="1" rowspan="1">DC (4)</td><td colspan="1" rowspan="1">Positive (15)</td><td colspan="1" rowspan="1">G2 (31)</td><td colspan="1" rowspan="1">pTis (0)</td><td colspan="1" rowspan="1">Median (28)</td></tr><tr><td colspan="1" rowspan="1">GR (5)</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">G3 (98)</td><td colspan="1" rowspan="1">pT1 (27)</td><td colspan="1" rowspan="1">Range (9&#8211;76)</td></tr><tr><td colspan="1" rowspan="1">PG (3)</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">G4 (1)</td><td colspan="1" rowspan="1">pT2 (73)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">PP (41)</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">pT3 (37)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">STP (4)</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">TP (5)</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">N/R</italic> not recorded, <italic toggle="yes">PP</italic> partial penectomy, <italic toggle="yes">TP</italic> total penectomy, <italic toggle="yes">STP</italic> subtotal penectomy, <italic toggle="yes">RC</italic> radical circumcision, <italic toggle="yes">CC</italic> circumcision, <italic toggle="yes">WLE</italic> wide local excision, <italic toggle="yes">TG</italic> total glansectomy, <italic toggle="yes">GL</italic> glansectomy, <italic toggle="yes">GR</italic> glans resurfacing, <italic toggle="yes">PG</italic> partial glansectomy, <italic toggle="yes">DC</italic> distal corporectomy.</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec10"><title>Accuracy of frozen section examination margin reports</title><p id="Par22">FSE for PeCa is not routinely used for initial diagnostic purposes. Instead, margins are taken to confirm the complete excision of the tumour. The sensitivity, specificity, PPV, NPV, and accuracy results are summarised in Table&#160;<xref rid="Tab2" ref-type="table">2</xref>. In both Li et al. and Morelli et al.&#8217;s studies, there was 100% concordance, the PPV and sensitivity calculation cannot be calculated due to 0 patients with positive margin values [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. All studies showed a high percentage accuracy of intraoperative FSE with a range from 92.9 to 99.4% and a mean accuracy of 95.4%. Additionally, the mean sensitivity, specificity, PPV, and NPV were 71.4%, 99.9%, 98.8%, and 96.5%, respectively [<xref ref-type="bibr" rid="CR18">18</xref>&#8211;<xref ref-type="bibr" rid="CR24">24</xref>].<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Accuracy of reports comparing FSE of margins results with final histopathology.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Study</th><th colspan="1" rowspan="1">Year</th><th colspan="1" rowspan="1">FSE (<italic toggle="yes">n</italic>)</th><th colspan="1" rowspan="1">Atypical</th><th colspan="1" rowspan="1">TP</th><th colspan="1" rowspan="1">FP</th><th colspan="1" rowspan="1">FN</th><th colspan="1" rowspan="1">TN</th><th colspan="1" rowspan="1">Sensitivity% (95% CI)</th><th colspan="1" rowspan="1">Specificity% (95% CI)</th><th colspan="1" rowspan="1">PPV% (95% CI)</th><th colspan="1" rowspan="1">NPV (95% CI)</th><th colspan="1" rowspan="1">Accuracy%</th></tr></thead><tbody><tr><td rowspan="2" colspan="1">Li et al. [<xref ref-type="bibr" rid="CR18">18</xref>]</td><td rowspan="2" colspan="1">2011</td><td rowspan="2" colspan="1">32</td><td rowspan="2" colspan="1">0</td><td rowspan="2" colspan="1">0</td><td rowspan="2" colspan="1">0</td><td rowspan="2" colspan="1">0</td><td rowspan="2" colspan="1">32</td><td rowspan="2" colspan="1">N/R</td><td colspan="1" rowspan="1">100</td><td rowspan="2" colspan="1">N/R</td><td colspan="1" rowspan="1">100</td><td rowspan="2" colspan="1">N/R</td></tr><tr><td colspan="1" rowspan="1">(89.1&#8211;100)</td><td colspan="1" rowspan="1">(89.1&#8211;100)</td></tr><tr><td rowspan="2" colspan="1">Morelli et al. [<xref ref-type="bibr" rid="CR19">19</xref>]</td><td rowspan="2" colspan="1">2009</td><td rowspan="2" colspan="1">15</td><td rowspan="2" colspan="1">0</td><td rowspan="2" colspan="1">0</td><td rowspan="2" colspan="1">0</td><td rowspan="2" colspan="1">0</td><td rowspan="2" colspan="1">15</td><td rowspan="2" colspan="1">N/R</td><td colspan="1" rowspan="1">100</td><td rowspan="2" colspan="1">N/R</td><td colspan="1" rowspan="1">100</td><td rowspan="2" colspan="1">N/R</td></tr><tr><td colspan="1" rowspan="1">(78.2&#8211;100)</td><td colspan="1" rowspan="1">(78.2&#8211;100)</td></tr><tr><td rowspan="2" colspan="1">Danakas et al. [<xref ref-type="bibr" rid="CR20">20</xref>]</td><td rowspan="2" colspan="1">2018</td><td rowspan="2" colspan="1">31</td><td rowspan="2" colspan="1">3</td><td rowspan="2" colspan="1">3</td><td rowspan="2" colspan="1">0</td><td rowspan="2" colspan="1">2</td><td rowspan="2" colspan="1">23</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">92</td><td colspan="1" rowspan="1">92.9</td></tr><tr><td colspan="1" rowspan="1">(14.7&#8211;94.7)</td><td colspan="1" rowspan="1">(85.2&#8211;100)</td><td colspan="1" rowspan="1">(29.2&#8211;100)</td><td colspan="1" rowspan="1">(79.7&#8211;97.1)</td><td colspan="1" rowspan="1">(76.5&#8211;99.1)</td></tr><tr><td rowspan="2" colspan="1">Ellul et al. [<xref ref-type="bibr" rid="CR21">21</xref>]</td><td rowspan="2" colspan="1">2020</td><td rowspan="2" colspan="1">169</td><td rowspan="2" colspan="1">1</td><td rowspan="2" colspan="1">20</td><td rowspan="2" colspan="1">1</td><td rowspan="2" colspan="1">0</td><td rowspan="2" colspan="1">147</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">99.3</td><td colspan="1" rowspan="1">95.2</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">99.4</td></tr><tr><td colspan="1" rowspan="1">(83.2&#8211;100)</td><td colspan="1" rowspan="1">(96.3&#8211;100)</td><td colspan="1" rowspan="1">(73.9&#8211;99.3)</td><td colspan="1" rowspan="1">(97.5&#8211;100)</td><td colspan="1" rowspan="1">(96.7&#8211;100)</td></tr><tr><td rowspan="2" colspan="1">O&#8217;Kelly et al. [<xref ref-type="bibr" rid="CR22">22</xref>]</td><td rowspan="2" colspan="1">2017</td><td rowspan="2" colspan="1">19</td><td rowspan="2" colspan="1">0</td><td rowspan="2" colspan="1">0</td><td rowspan="2" colspan="1">0</td><td rowspan="2" colspan="1">1</td><td rowspan="2" colspan="1">18</td><td rowspan="2" colspan="1">N/R</td><td colspan="1" rowspan="1">100</td><td rowspan="2" colspan="1">N/R</td><td colspan="1" rowspan="1">94.7</td><td colspan="1" rowspan="1">94.7</td></tr><tr><td colspan="1" rowspan="1">(81.5&#8211;100)</td><td colspan="1" rowspan="1">(94.7&#8211;94.7)</td><td colspan="1" rowspan="1">(74.0&#8211;99.9)</td></tr><tr><td rowspan="2" colspan="1">Parnham et al. [<xref ref-type="bibr" rid="CR23">23</xref>]</td><td rowspan="2" colspan="1">2018</td><td rowspan="2" colspan="1">171</td><td rowspan="2" colspan="1">0</td><td rowspan="2" colspan="1">10</td><td rowspan="2" colspan="1">0</td><td rowspan="2" colspan="1">7</td><td rowspan="2" colspan="1">154</td><td colspan="1" rowspan="1">58.8</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">95.7</td><td colspan="1" rowspan="1">96</td></tr><tr><td colspan="1" rowspan="1">(32.9&#8211;81.6)</td><td colspan="1" rowspan="1">(97.6&#8211;100)</td><td colspan="1" rowspan="1">(69.2&#8211;100)</td><td colspan="1" rowspan="1">(92.6&#8211;97.5)</td><td colspan="1" rowspan="1">(91.8&#8211;98.3)</td></tr><tr><td rowspan="2" colspan="1">Pang and Yunis et al. [<xref ref-type="bibr" rid="CR24">24</xref>]</td><td rowspan="2" colspan="1">2024</td><td rowspan="2" colspan="1">137</td><td rowspan="2" colspan="1">3</td><td rowspan="2" colspan="1">16</td><td rowspan="2" colspan="1">0</td><td rowspan="2" colspan="1">8</td><td rowspan="2" colspan="1">110</td><td colspan="1" rowspan="1">66.7</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">93.2</td><td colspan="1" rowspan="1">94</td></tr><tr><td colspan="1" rowspan="1">(44.7&#8211;84.4)</td><td colspan="1" rowspan="1">(96.7&#8211;100)</td><td colspan="1" rowspan="1">(79.4&#8211;100)</td><td colspan="1" rowspan="1">(88.7&#8211;96.0)</td><td colspan="1" rowspan="1">(88.6&#8211;97.4)</td></tr></tbody></table><table-wrap-foot><p>Analysis performed with MedCalc [<xref ref-type="bibr" rid="CR15">15</xref>].</p><p><italic toggle="yes">FSE</italic> frozen section assessment, <italic toggle="yes">TP</italic> true positive, <italic toggle="yes">FP</italic> false positive, <italic toggle="yes">FN</italic> false negative, <italic toggle="yes">TN</italic> true negative, <italic toggle="yes">CI</italic> confidence interval, <italic toggle="yes">PPV</italic> positive predictive value, <italic toggle="yes">NPV</italic> negative predictive value, <italic toggle="yes">N/R</italic> not recorded.</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec11"><title>Indications of frozen section examination in penile cancer surgery</title><p id="Par23">Radical penectomy and total penectomy can have intraoperative FSE indications for ensuring that the excision margin is clear of PeCa. Intraoperative FSE during total penectomy is performed at the discretion of the surgeon or in line with the departmental policy. Danakas et al. showed the benefit of FSE during total penectomy with 4 cases showing negative conversion of margins with initial positive or atypical FSE. However, they concluded that there was not a significant impact on final surgical margin status nor long-term oncologic outcomes with the use of FSE [<xref ref-type="bibr" rid="CR20">20</xref>].</p><p id="Par24">PPS can be performed in cases where it is possible to completely excise the tumour and maintain a functional penile length. Studies utilising partial penectomy, radical circumcision, wide local excision (WLE), glansectomy and glans resurfacing were reviewed. Parnham et al. presented 171/177 patients from February 2005 to January 2016 who underwent glansectomy and split-thickness skin graft (STSG) with intraoperative FSE. They described biopsies of the complete circumference of the urethra and of each corporal tip which was sent for FSE. These improved outcomes in at least 10 patients who had further resection following a positive FSE result [<xref ref-type="bibr" rid="CR23">23</xref>]. A further 15 cases of glansectomy were shown to prove 100% accuracy [<xref ref-type="bibr" rid="CR19">19</xref>]. Additionally, FSE can be performed in total glans resurfacing where spongiosal biopsies of the deep margin are taken. O&#8217;Kelly et al. presented total glans resurfacing, showing 95% accuracy of FSE where one case had an FN result [<xref ref-type="bibr" rid="CR22">22</xref>].</p></sec><sec id="Sec12"><title>Final margin status and risk of recurrence</title><p id="Par25">Local recurrence (LR) was a secondary outcome measure assessed. One study suggested that LR most likely occurs within 6 months post-operation [<xref ref-type="bibr" rid="CR18">18</xref>], whereas another suggested that it occurs within 2 years [<xref ref-type="bibr" rid="CR21">21</xref>]. Two studies provided the median time of recurrence at 8.7 and 10 months [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. The range of LR in all studies was 0&#8211;16%, although patients were not followed up for the same amount of time in the selected reports, the mean risk of patients having a local recurrence was 7.9% across all studies [<xref ref-type="bibr" rid="CR18">18</xref>&#8211;<xref ref-type="bibr" rid="CR24">24</xref>]. Danakas et al. suggested that patients with positive surgical margins tend to have a higher risk for disease recurrence, compared with those with negative surgical margins [<xref ref-type="bibr" rid="CR20">20</xref>]. This suggested that the risk of a positive margin is greater when PeCa is removed without the use of intraoperative FSE. Pang and Yunis et al. examined the local recurrence rate in 137 patients undergoing PPS surgery for penile SCC. In this study, the overall LR rate was 10.2%. Among patients with positive FSE margins, the recurrence rate was higher at 25%, compared to 8.5% in those with negative FSE margins [<xref ref-type="bibr" rid="CR24">24</xref>]. This suggested that positive surgical margins, even when identified and addressed with further resection during surgery, may still carry a higher risk of LR.</p></sec><sec id="Sec13"><title>Postoperative complications and patient-reported outcomes</title><p id="Par26">Across 4 studies, where complications were reported, there was an average complication rate of 17.7% [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Li et al. presented 3/32 (9.4%) complications where 2 patients had wound dehiscence, and 1 patient had the formation of a local abscess [<xref ref-type="bibr" rid="CR18">18</xref>]. Whilst Morelli et al. presented a higher rate of complications at 26.7% with 2 partial graft loss&#8217;, 1 meatal stenosis, and 1 phimosis [<xref ref-type="bibr" rid="CR19">19</xref>]. The highest complication rate in one study was 34.5%, where 29 patients had partial graft loss, 5 had complete or near-complete graft loss, 12 underwent regrafting, and 4 reported meatal stenosis [<xref ref-type="bibr" rid="CR23">23</xref>]. Depending on the type of complication, the patients underwent further surgery, required pharmacological intervention to manage the complication or had conservative management. However, one study reported 0% complications following 19 total glans resurfacing operations [<xref ref-type="bibr" rid="CR22">22</xref>]. Additionally, 3 studies assessed changes in sexual function. One study showed that 24.1% of patients maintained poor sexual function, and the other 75.9% had no change after surgery [<xref ref-type="bibr" rid="CR18">18</xref>]. Whereas another study presented an 81% improvement in sexual function [<xref ref-type="bibr" rid="CR19">19</xref>]. The final study maintained sexual functionality in all patients [<xref ref-type="bibr" rid="CR22">22</xref>].</p><p id="Par27">Two studies from this review analysed metastatic disease following surgery. Pang and Yunis et al. show 24.1% of patients with regional or distant metastasis post-surgery with a median follow-up to metastasis of 5 months [<xref ref-type="bibr" rid="CR24">24</xref>]. Li et al.&#8217;s cohort of patients had 5 (15.6%) with lymph node metastases, none of whom had adjuvant therapy before or after surgery. All of their patients reported satisfactory urination [<xref ref-type="bibr" rid="CR18">18</xref>].</p></sec><sec id="Sec14"><title>Validity assessment</title><p id="Par28">The RoB was evaluated in each of the papers, results are outlined in Supplementary Table&#160;<xref rid="MOESM2" ref-type="media">3</xref>. Danakas et al. received a high-quality rating, whilst the other 6 studies received a moderate-quality rating [<xref ref-type="bibr" rid="CR18">18</xref>&#8211;<xref ref-type="bibr" rid="CR24">24</xref>]. Confounders were identified in each of the studies, which included tumour stage, tumour grade, nodal stage, quality of excision (surgeon preference or case complexity), and prior therapy, however, Danakas et al. showed no statistically significant difference in the histopathological characteristics of the patients [<xref ref-type="bibr" rid="CR20">20</xref>].</p></sec></sec><sec id="Sec15" sec-type="discussion"><title>Discussion</title><p id="Par29">The accuracy of FSE is an important factor to consider when deciding whether its use is valuable intraoperatively. FSE is labour-intensive due to the requirement of available dedicated expert histopathologists, pathology technicians and porters. It is also time-consuming and lengthens the surgery. Some studies have indicated that it is not 100% accurate in its assessment of margins [<xref ref-type="bibr" rid="CR25">25</xref>], therefore, it is important to weigh the benefits and risks of intraoperative FSE. With the use of intraoperative FSE, it is possible to operate with less macroscopic surgical clearance and re-resect the margins under the same general anaesthetic in the event of a positive margin. This approach reduces the need to reoperate in the future and hence reduces the risk of LR [<xref ref-type="bibr" rid="CR26">26</xref>]. Our results showed that FSE is accurate in the assessment of penile surgical margins, and it is important to note that there are multiple other studies which advocate the use of FSE during PeCa to attain negative margins [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. Follow-up for local PeCa recurrence should be done every 3 months for the first 2 years and then every 6 months until at least 5 years post-operatively for PPS [<xref ref-type="bibr" rid="CR9">9</xref>]. FSE may reduce the risk of recurrence which may be due to the better attainment of negative margins. A study in 2004 by Pietrzak et al. showed that intraoperative FSE can maintain penile length, shape and function without reducing oncological control, and 2 patients who did not have FSE had early complications [<xref ref-type="bibr" rid="CR29">29</xref>]. Preserved penile form and functional outcomes have been associated with PPS. Partial or total penectomy is associated with major sexual and functional compromise. It is also associated with substantial psychological deficits in more than 50% of patients [<xref ref-type="bibr" rid="CR30">30</xref>]. Emerging technologies such as optical biopsy with in vivo confocal laser endomicroscopy (CLE) offer a potential alternative or adjunct to FSE. CLE allows for instantaneous real-time, non-invasive visualisation of tissue microstructure, potentially aiding in margin assessment and reducing the need for excisional biopsies [<xref ref-type="bibr" rid="CR31">31</xref>].</p><sec id="Sec16"><title>Limitations</title><p id="Par30">Whilst FSE can be used to confirm negative margins in partial or total penectomy, it is also advantageous in PPS [<xref ref-type="bibr" rid="CR25">25</xref>]. Our results reflect the positive outcomes of several types of PPS but are also a limitation due to the lack of continuity in the types of surgeries included and the retrospective nature of the studies. As there have not been many published reports on the accuracy of FSE, we have pooled all types of PPS and radical penectomy. More data is required on this topic before stronger evidence, including a meta-analysis, can be performed. Furthermore, there are limited reports comparing FSE to control, and this may be due to ethical considerations and different departmental protocols for operating. Other limitations of the studies included a small sample size as there have not been any large prospective studies to date. Additionally, there was a scope of selection bias as the FSE cases were not randomised. Another limitation of our study was the atypical results in FSE, all of which had further excision of tissue [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR24">24</xref>], but our method of analysis with MedCalc did not have an input for atypical results [<xref ref-type="bibr" rid="CR15">15</xref>]. Although atypical results are rare, it does put a patient at increased risk of having further tissue excised leading to a short penile stump which can result in sexual dysfunction, negative mental implications and voiding issues, when the margins are already negative. Additionally, every study included was subject to confounding factors, the largest being different surgery types leading to different outcomes. More reports are required before a review can be done for each specific surgical procedure for the treatment of PeCa.</p></sec><sec id="Sec17"><title>Clinical implications</title><p id="Par31">Our results reflect that FSE use in clinical practice is safe and practical, in cases where the resection margins are uncertain. It can be used in line with PPS techniques to give patients greater functional outcomes, whilst maintaining good oncological control with a reduced risk of recurrence, all without the need for a further surgical and anaesthetic episode. Both the surgeon and histopathologist have crucial roles in excising oncologically safe and complete margins and giving accurate clinical information, respectively. For best results, close communication between both the surgeon and histopathologist is suggested to be critical for the assessment of frozen section specimens [<xref ref-type="bibr" rid="CR11">11</xref>]. Future research should not only focus on larger, prospective studies comparing FSE to control groups but also explore the potential of CLE in PeCa management. Investigating the diagnostic accuracy, feasibility, and impact of CLE on surgical decision-making and patient outcomes could reveal its potential to complement or even replace FSE in certain scenarios.</p></sec></sec><sec id="Sec18" sec-type="conclusion"><title>Conclusions</title><p id="Par32">The evidence involving FSE is still evolving. There are clear advantages of performing FSE, with reports of high accuracy. FSE enables operating surgeons to excise a penile tumour with the confidence of being able to achieve negative surgical margins. As a result, the risk of LR is reduced with improved patient-reported outcomes. However, PeCa is rare and as centralisation of care and multi-institutional collaboration increases there will be further evidence on the accuracy of FSE.</p></sec><sec id="Sec19" sec-type="supplementary-material"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41443_2025_1024_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Supplemental Material 2</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41443_2025_1024_MOESM2_ESM.docx" position="float" orientation="portrait"><caption><p>Supplemental Material 3</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41443_2025_1024_MOESM3_ESM.docx" position="float" orientation="portrait"><caption><p>Sup Table 1 FSE PeCa SR PRISMA checklist REVISED</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Mohammad Z. Yunis, Karl H. Pang.</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1038/s41443-025-01024-7.</p></sec><notes notes-type="author-contribution"><title>Author contributions</title><p>Conceived and/or designed the work that led to the submission: KHP, AM, HMA; acquired data, and/or played an important role in interpreting the results: MZY, KHP. Drafted or revised the manuscript: MZY, KHP, AM, HMA. Approved the final version: MZY, KHP, AM, HMA. Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved: MZY, KHP, AM, HMA.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in this published article [and its supplementary information files].</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par33">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hernandez</surname><given-names>BY</given-names></name><name name-style="western"><surname>Barnholtz-Sloan</surname><given-names>J</given-names></name><name name-style="western"><surname>German</surname><given-names>RR</given-names></name><name name-style="western"><surname>Giuliano</surname><given-names>A</given-names></name><name name-style="western"><surname>Goodman</surname><given-names>MT</given-names></name><name name-style="western"><surname>King</surname><given-names>JB</given-names></name><etal/></person-group><article-title>Burden of invasive squamous cell carcinoma of the penis in the United States, 1998&#8211;2003</article-title><source>Cancer</source><year>2008</year><volume>113</volume><fpage>2883</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1002/CNCR.23743</pub-id><pub-id pub-id-type="pmid">18980292</pub-id><pub-id pub-id-type="pmcid">PMC2693711</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Hernandez BY, Barnholtz-Sloan J, German RR, Giuliano A, Goodman MT, King JB, et al. Burden of invasive squamous cell carcinoma of the penis in the United States, 1998&#8211;2003. Cancer. 2008;113:2883&#8211;91. 10.1002/CNCR.23743.<pub-id pub-id-type="pmid">18980292</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cncr.23743</pub-id><pub-id pub-id-type="pmcid">PMC2693711</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bray</surname><given-names>F</given-names></name><name name-style="western"><surname>Laversanne</surname><given-names>M</given-names></name><name name-style="western"><surname>Sung</surname><given-names>H</given-names></name><name name-style="western"><surname>Ferlay</surname><given-names>J</given-names></name><name name-style="western"><surname>Siegel</surname><given-names>RL</given-names></name><name name-style="western"><surname>Soerjomataram</surname><given-names>I</given-names></name><etal/></person-group><article-title>Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title><source>CA Cancer J Clin</source><year>2024</year><volume>74</volume><fpage>229</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.3322/CAAC.21834</pub-id><pub-id pub-id-type="pmid">38572751</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229&#8211;63. 10.3322/CAAC.21834.<pub-id pub-id-type="pmid">38572751</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3322/caac.21834</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verhoeven</surname><given-names>RHA</given-names></name><name name-style="western"><surname>Janssen-Heijnen</surname><given-names>MLG</given-names></name><name name-style="western"><surname>Saum</surname><given-names>KU</given-names></name><name name-style="western"><surname>Zanetti</surname><given-names>R</given-names></name><name name-style="western"><surname>Caldarella</surname><given-names>A</given-names></name><name name-style="western"><surname>Holleczek</surname><given-names>B</given-names></name><etal/></person-group><article-title>Population-based survival of penile cancer patients in Europe and the United States of America: no improvement since 1990</article-title><source>Eur J Cancer</source><year>2013</year><volume>49</volume><fpage>1414</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/J.EJCA.2012.10.029</pub-id><pub-id pub-id-type="pmid">23231984</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Verhoeven RHA, Janssen-Heijnen MLG, Saum KU, Zanetti R, Caldarella A, Holleczek B, et al. Population-based survival of penile cancer patients in Europe and the United States of America: no improvement since 1990. Eur J Cancer. 2013;49:1414&#8211;21. 10.1016/J.EJCA.2012.10.029.<pub-id pub-id-type="pmid">23231984</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejca.2012.10.029</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Engelsgjerd JS, Leslie SW, LaGrange CA. Penile cancer and penile intraepithelial neoplasia. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2024.<pub-id pub-id-type="pmid">29763105</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Minhas</surname><given-names>S</given-names></name><name name-style="western"><surname>Kayes</surname><given-names>O</given-names></name><name name-style="western"><surname>Hegarty</surname><given-names>P</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>P</given-names></name><name name-style="western"><surname>Freeman</surname><given-names>A</given-names></name><name name-style="western"><surname>Ralph</surname><given-names>D</given-names></name></person-group><article-title>What surgical resection margins are required to achieve oncological control in men with primary penile cancer?</article-title><source>BJU Int</source><year>2005</year><volume>96</volume><fpage>1040</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1111/J.1464-410X.2005.05769.X</pub-id><pub-id pub-id-type="pmid">16225525</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Minhas S, Kayes O, Hegarty P, Kumar P, Freeman A, Ralph D. What surgical resection margins are required to achieve oncological control in men with primary penile cancer? BJU Int. 2005;96:1040&#8211;3. 10.1111/J.1464-410X.2005.05769.X.<pub-id pub-id-type="pmid">16225525</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1464-410X.2005.05769.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>E</given-names></name><name name-style="western"><surname>Yao</surname><given-names>HH</given-names></name><name name-style="western"><surname>Chee</surname><given-names>J</given-names></name></person-group><article-title>Optimal surgical margin for penile-sparing surgery in management of penile cancer-Is 2 cm really necessary?</article-title><source>BJUI Compass</source><year>2021</year><volume>2</volume><fpage>281</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1002/BCO2.75</pub-id><pub-id pub-id-type="pmid">35475297</pub-id><pub-id pub-id-type="pmcid">PMC8988642</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Anderson E, Yao HH, Chee J. Optimal surgical margin for penile-sparing surgery in management of penile cancer-Is 2 cm really necessary? BJUI Compass. 2021;2:281&#8211;5. 10.1002/BCO2.75.<pub-id pub-id-type="pmid">35475297</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/bco2.75</pub-id><pub-id pub-id-type="pmcid">PMC8988642</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baumgarten</surname><given-names>AS</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>JS</given-names></name><name name-style="western"><surname>Lawindy</surname><given-names>SM</given-names></name><name name-style="western"><surname>Pavlinec</surname><given-names>JG</given-names></name><name name-style="western"><surname>Carrion</surname><given-names>RE</given-names></name><name name-style="western"><surname>Spiess</surname><given-names>PE</given-names></name></person-group><article-title>Penile sparing surgical approaches for primary penile tumors: preserving function and appearance</article-title><source>Transl Androl Urol</source><year>2017</year><volume>6</volume><fpage>809.</fpage><pub-id pub-id-type="doi">10.21037/TAU.2017.04.01</pub-id><pub-id pub-id-type="pmid">29184777</pub-id><pub-id pub-id-type="pmcid">PMC5673820</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Baumgarten AS, Fisher JS, Lawindy SM, Pavlinec JG, Carrion RE, Spiess PE. Penile sparing surgical approaches for primary penile tumors: preserving function and appearance. Transl Androl Urol. 2017;6:809. 10.21037/TAU.2017.04.01.<pub-id pub-id-type="pmid">29184777</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/tau.2017.04.01</pub-id><pub-id pub-id-type="pmcid">PMC5673820</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kitamura</surname><given-names>Y</given-names></name><name name-style="western"><surname>Horiguchi</surname><given-names>A</given-names></name><name name-style="western"><surname>Ojima</surname><given-names>K</given-names></name><name name-style="western"><surname>Kawamura</surname><given-names>K</given-names></name><name name-style="western"><surname>Shinchi</surname><given-names>M</given-names></name><name name-style="western"><surname>Asano</surname><given-names>T</given-names></name><etal/></person-group><article-title>Penile&#8208;preserving surgery for male distal urethral carcinoma followed by buccal mucosa urethroplasty</article-title><source>IJU Case Rep</source><year>2019</year><volume>2</volume><fpage>198.</fpage><pub-id pub-id-type="doi">10.1002/IJU5.12076</pub-id><pub-id pub-id-type="pmid">32743412</pub-id><pub-id pub-id-type="pmcid">PMC7292118</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Kitamura Y, Horiguchi A, Ojima K, Kawamura K, Shinchi M, Asano T, et al. Penile&#8208;preserving surgery for male distal urethral carcinoma followed by buccal mucosa urethroplasty. IJU Case Rep. 2019;2:198. 10.1002/IJU5.12076.<pub-id pub-id-type="pmid">32743412</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/iju5.12076</pub-id><pub-id pub-id-type="pmcid">PMC7292118</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="other">Brouwer OR, Tagawa ST, Albersen M, Ayres B, Crook J, van der Heijden MS, et al. EAU guidelines. Edn. Presented at the EAU annual congress Paris 2024. European Association of Urology; 2024. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://uroweb.org/guidelines/penile-cancer">https://uroweb.org/guidelines/penile-cancer</ext-link>.</mixed-citation></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miyamoto</surname><given-names>H</given-names></name></person-group><article-title>Clinical benefits of frozen section assessment during urological surgery: Does it contribute to improving surgical margin status and patient outcomes as previously thought?</article-title><source>Int J Urol</source><year>2017</year><volume>24</volume><fpage>25</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1111/IJU.13247</pub-id><pub-id pub-id-type="pmid">27862367</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Miyamoto H. Clinical benefits of frozen section assessment during urological surgery: Does it contribute to improving surgical margin status and patient outcomes as previously thought? Int J Urol. 2017;24:25&#8211;31. 10.1111/IJU.13247.<pub-id pub-id-type="pmid">27862367</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/iju.13247</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>SS</given-names></name><name name-style="western"><surname>Truong</surname><given-names>LD</given-names></name><name name-style="western"><surname>Ro</surname><given-names>JY</given-names></name><name name-style="western"><surname>Ayala</surname><given-names>AG</given-names></name></person-group><article-title>Use of frozen section in genitourinary pathology</article-title><source>Pathology</source><year>2012</year><volume>44</volume><fpage>427</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1097/PAT.0B013E328356A79E</pub-id><pub-id pub-id-type="pmid">22772345</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Shen SS, Truong LD, Ro JY, Ayala AG. Use of frozen section in genitourinary pathology. Pathology. 2012;44:427&#8211;33. 10.1097/PAT.0B013E328356A79E.<pub-id pub-id-type="pmid">22772345</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/PAT.0b013e328356a79e</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seixas</surname><given-names>ALC</given-names></name><name name-style="western"><surname>Ornellas</surname><given-names>AA</given-names></name><name name-style="western"><surname>Marota</surname><given-names>A</given-names></name><name name-style="western"><surname>Wisnescky</surname><given-names>A</given-names></name><name name-style="western"><surname>Campos</surname><given-names>F</given-names></name><name name-style="western"><surname>De Moraes</surname><given-names>JR</given-names></name><etal/></person-group><article-title>Verrucous carcinoma of the penis: retrospective analysis of 32 cases</article-title><source>J Urol</source><year>1994</year><volume>152</volume><fpage>1476</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/S0022-5347(17)32450-3</pub-id><pub-id pub-id-type="pmid">7933188</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Seixas ALC, Ornellas AA, Marota A, Wisnescky A, Campos F, De Moraes JR, et al. Verrucous carcinoma of the penis: retrospective analysis of 32 cases. J Urol. 1994;152:1476&#8211;8. 10.1016/S0022-5347(17)32450-3.<pub-id pub-id-type="pmid">7933188</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0022-5347(17)32450-3</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021. 10.1136/BMJ.N71.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.n71</pub-id><pub-id pub-id-type="pmcid">PMC8005924</pub-id><pub-id pub-id-type="pmid">33782057</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="other">The EndNote Team. EndNote Philadelphia, PA: Clarivate; 2013. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://endnote.com/?srsltid=AfmBOopMILwH17_777SBLQncKBVMWPxnWQGmF6m7ZCTPHMkf11b-r8EJ">https://endnote.com/?srsltid=AfmBOopMILwH17_777SBLQncKBVMWPxnWQGmF6m7ZCTPHMkf11b-r8EJ</ext-link>.</mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">MedCalc&#8217;s Diagnostic test evaluation calculator n.d. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.medcalc.org/calc/diagnostic_test.php">https://www.medcalc.org/calc/diagnostic_test.php</ext-link>. Accessed 23 Sep 2024).</mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [abstract] - Cochrane Methodology Register n.d. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://cmr.cochrane.org/?CRGReportID=2972">https://cmr.cochrane.org/?CRGReportID=2972</ext-link>. Accessed 23 Sep 2024).</mixed-citation></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murad</surname><given-names>MH</given-names></name><name name-style="western"><surname>Sultan</surname><given-names>S</given-names></name><name name-style="western"><surname>Haffar</surname><given-names>S</given-names></name><name name-style="western"><surname>Bazerbachi</surname><given-names>F</given-names></name><name name-style="western"><surname>Mohammad</surname><given-names>D</given-names></name><name name-style="western"><surname>Murad</surname><given-names>H</given-names></name></person-group><article-title>Methodological quality and synthesis of case series and case reports</article-title><source>BMJ Evid Based Med</source><year>2018</year><volume>23</volume><fpage>60</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1136/bmjebm-2017-110853</pub-id><pub-id pub-id-type="pmid">29420178</pub-id><pub-id pub-id-type="pmcid">PMC6234235</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Murad MH, Sultan S, Haffar S, Bazerbachi F, Mohammad D, Murad H. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med. 2018;23:60&#8211;3. 10.1136/bmjebm-2017-110853.<pub-id pub-id-type="pmid">29420178</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjebm-2017-110853</pub-id><pub-id pub-id-type="pmcid">PMC6234235</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>SL</given-names></name><name name-style="western"><surname>Wang</surname><given-names>CF</given-names></name><name name-style="western"><surname>Yao</surname><given-names>XD</given-names></name><name name-style="western"><surname>Dai</surname><given-names>B</given-names></name><etal/></person-group><article-title>Organ-sparing surgery for penile cancer: complications and outcomes</article-title><source>Urology</source><year>2011</year><volume>78</volume><fpage>1121</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1016/J.UROLOGY.2011.08.006</pub-id><pub-id pub-id-type="pmid">22054385</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Li J, Zhu Y, Zhang SL, Wang CF, Yao XD, Dai B, et al. Organ-sparing surgery for penile cancer: complications and outcomes. Urology. 2011;78:1121&#8211;4. 10.1016/J.UROLOGY.2011.08.006.<pub-id pub-id-type="pmid">22054385</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.urology.2011.08.006</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morelli</surname><given-names>G</given-names></name><name name-style="western"><surname>Pagni</surname><given-names>R</given-names></name><name name-style="western"><surname>Mariani</surname><given-names>C</given-names></name><name name-style="western"><surname>Campo</surname><given-names>G</given-names></name><name name-style="western"><surname>Menchini-Fabris</surname><given-names>F</given-names></name><name name-style="western"><surname>Minervini</surname><given-names>R</given-names></name><etal/></person-group><article-title>Glansectomy with split-thickness skin graft for the treatment of penile carcinoma</article-title><source>Int J Impot Res</source><year>2009</year><volume>21</volume><fpage>311</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1038/IJIR.2009.17</pub-id><pub-id pub-id-type="pmid">19458620</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Morelli G, Pagni R, Mariani C, Campo G, Menchini-Fabris F, Minervini R, et al. Glansectomy with split-thickness skin graft for the treatment of penile carcinoma. Int J Impot Res. 2009;21:311&#8211;4. 10.1038/IJIR.2009.17.<pub-id pub-id-type="pmid">19458620</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ijir.2009.17</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Danakas</surname><given-names>AM</given-names></name><name name-style="western"><surname>Bsirini</surname><given-names>C</given-names></name><name name-style="western"><surname>Miyamoto</surname><given-names>H</given-names></name></person-group><article-title>The impact of routine frozen section assessment during penectomy on surgical margin status and long-term oncologic outcomes</article-title><source>Pathol Oncol Res</source><year>2018</year><volume>24</volume><fpage>947</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1007/S12253-018-0439-Z</pub-id><pub-id pub-id-type="pmid">29862472</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Danakas AM, Bsirini C, Miyamoto H. The impact of routine frozen section assessment during penectomy on surgical margin status and long-term oncologic outcomes. Pathol Oncol Res. 2018;24:947&#8211;50. 10.1007/S12253-018-0439-Z.<pub-id pub-id-type="pmid">29862472</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12253-018-0439-z</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ellul</surname><given-names>T</given-names></name><name name-style="western"><surname>Grice</surname><given-names>P</given-names></name><name name-style="western"><surname>Mainwaring</surname><given-names>A</given-names></name><name name-style="western"><surname>Bullock</surname><given-names>N</given-names></name><name name-style="western"><surname>Shanahan</surname><given-names>A</given-names></name><name name-style="western"><surname>Cave</surname><given-names>D</given-names></name><etal/></person-group><article-title>Frozen section analysis for organ-conserving surgery in penile cancer: assessing oncological outcomes and trends of local recurrence</article-title><source>J Clin Urol</source><year>2020</year><volume>13</volume><fpage>419</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1177/2051415820903192</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Ellul T, Grice P, Mainwaring A, Bullock N, Shanahan A, Cave D, et al. Frozen section analysis for organ-conserving surgery in penile cancer: assessing oncological outcomes and trends of local recurrence. J Clin Urol. 2020;13:419&#8211;24. 10.1177/2051415820903192.</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Kelly</surname><given-names>F</given-names></name><name name-style="western"><surname>Lonergan</surname><given-names>P</given-names></name><name name-style="western"><surname>Lundon</surname><given-names>D</given-names></name><name name-style="western"><surname>Nason</surname><given-names>G</given-names></name><name name-style="western"><surname>Sweeney</surname><given-names>P</given-names></name><name name-style="western"><surname>Cullen</surname><given-names>I</given-names></name><etal/></person-group><article-title>A prospective study of total glans resurfacing for localized penile cancer to maximize oncologic and functional outcomes in a tertiary referral network</article-title><source>J Urol</source><year>2017</year><volume>197</volume><fpage>1258</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/J.JURO.2016.12.089</pub-id><pub-id pub-id-type="pmid">28027867</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">O&#8217;Kelly F, Lonergan P, Lundon D, Nason G, Sweeney P, Cullen I, et al. A prospective study of total glans resurfacing for localized penile cancer to maximize oncologic and functional outcomes in a tertiary referral network. J Urol. 2017;197:1258&#8211;63. 10.1016/J.JURO.2016.12.089.<pub-id pub-id-type="pmid">28027867</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.juro.2016.12.089</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parnham</surname><given-names>AS</given-names></name><name name-style="western"><surname>Albersen</surname><given-names>M</given-names></name><name name-style="western"><surname>Sahdev</surname><given-names>V</given-names></name><name name-style="western"><surname>Christodoulidou</surname><given-names>M</given-names></name><name name-style="western"><surname>Nigam</surname><given-names>R</given-names></name><name name-style="western"><surname>Malone</surname><given-names>P</given-names></name><etal/></person-group><article-title>Glansectomy and split-thickness skin graft for penile cancer</article-title><source>Eur Urol</source><year>2018</year><volume>73</volume><fpage>284</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/J.EURURO.2016.09.048</pub-id><pub-id pub-id-type="pmid">27746062</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Parnham AS, Albersen M, Sahdev V, Christodoulidou M, Nigam R, Malone P, et al. Glansectomy and split-thickness skin graft for penile cancer. Eur Urol. 2018;73:284&#8211;9. 10.1016/J.EURURO.2016.09.048.<pub-id pub-id-type="pmid">27746062</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.eururo.2016.09.048</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pang</surname><given-names>KH</given-names></name><name name-style="western"><surname>Yunis</surname><given-names>M</given-names></name><name name-style="western"><surname>Haider</surname><given-names>A</given-names></name><name name-style="western"><surname>Freeman</surname><given-names>A</given-names></name><name name-style="western"><surname>Hadway</surname><given-names>P</given-names></name><name name-style="western"><surname>Nigam</surname><given-names>R</given-names></name><etal/></person-group><article-title>Outcomes of intraoperative frozen section examination of surgical resection margins of the penis in penile cancer</article-title><source>Clin Genitourin Cancer</source><year>2024</year><volume>22</volume><fpage>102189.</fpage><pub-id pub-id-type="doi">10.1016/j.clgc.2024.102189</pub-id><pub-id pub-id-type="pmid">39232874</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Pang KH, Yunis M, Haider A, Freeman A, Hadway P, Nigam R, et al. Outcomes of intraoperative frozen section examination of surgical resection margins of the penis in penile cancer. Clin Genitourin Cancer. 2024;22:102189. 10.1016/j.clgc.2024.102189.<pub-id pub-id-type="pmid">39232874</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.clgc.2024.102189</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamel</surname><given-names>MH</given-names></name><name name-style="western"><surname>Bissada</surname><given-names>N</given-names></name><name name-style="western"><surname>Warford</surname><given-names>R</given-names></name><name name-style="western"><surname>Farias</surname><given-names>J</given-names></name><name name-style="western"><surname>Davis</surname><given-names>R</given-names></name></person-group><article-title>Organ sparing surgery for penile cancer: a systematic review</article-title><source>J Urol</source><year>2017</year><volume>198</volume><fpage>770</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/J.JURO.2017.01.088</pub-id><pub-id pub-id-type="pmid">28286072</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Kamel MH, Bissada N, Warford R, Farias J, Davis R. Organ sparing surgery for penile cancer: a systematic review. J Urol. 2017;198:770&#8211;9. 10.1016/J.JURO.2017.01.088.<pub-id pub-id-type="pmid">28286072</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.juro.2017.01.088</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loughlin</surname><given-names>KR</given-names></name></person-group><article-title>Penile cancer sparing surgery: the balance between oncological cure and functional preservation</article-title><source>Urol Oncol</source><year>2018</year><volume>36</volume><fpage>153</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/J.UROLONC.2017.12.008</pub-id><pub-id pub-id-type="pmid">29306557</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Loughlin KR. Penile cancer sparing surgery: the balance between oncological cure and functional preservation. Urol Oncol. 2018;36:153&#8211;5. 10.1016/J.UROLONC.2017.12.008.<pub-id pub-id-type="pmid">29306557</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.urolonc.2017.12.008</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McDougal</surname><given-names>WS</given-names></name></person-group><article-title>Phallic preserving surgery in patients with invasive squamous cell carcinoma of the penis</article-title><source>J Urol</source><year>2005</year><volume>174</volume><fpage>2218</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1097/01.JU.0000181225.31468.82</pub-id><pub-id pub-id-type="pmid">16280767</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">McDougal WS. Phallic preserving surgery in patients with invasive squamous cell carcinoma of the penis. J Urol. 2005;174:2218&#8211;20. 10.1097/01.JU.0000181225.31468.82.<pub-id pub-id-type="pmid">16280767</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.ju.0000181225.31468.82</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chavarriaga</surname><given-names>J</given-names></name><name name-style="western"><surname>Pardo</surname><given-names>J</given-names></name><name name-style="western"><surname>Suso-Palau</surname><given-names>D</given-names></name><name name-style="western"><surname>Becerra</surname><given-names>L</given-names></name><name name-style="western"><surname>Camacho</surname><given-names>D</given-names></name><name name-style="western"><surname>Godoy</surname><given-names>F</given-names></name><etal/></person-group><article-title>Real world data of penile cancer treatment at a high-volume center in South America: insights and survival trends</article-title><source>Urology</source><year>2021</year><volume>156</volume><fpage>199</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1016/J.UROLOGY.2021.07.011</pub-id><pub-id pub-id-type="pmid">34310915</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Chavarriaga J, Pardo J, Suso-Palau D, Becerra L, Camacho D, Godoy F, et al. Real world data of penile cancer treatment at a high-volume center in South America: insights and survival trends. Urology. 2021;156:199&#8211;204. 10.1016/J.UROLOGY.2021.07.011.<pub-id pub-id-type="pmid">34310915</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.urology.2021.07.011</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pietrzak</surname><given-names>P</given-names></name><name name-style="western"><surname>Corbishley</surname><given-names>C</given-names></name><name name-style="western"><surname>Watkin</surname><given-names>N</given-names></name></person-group><article-title>Organ-sparing surgery for invasive penile cancer: early follow-up data</article-title><source>BJU Int</source><year>2004</year><volume>94</volume><fpage>1253</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1111/J.1464-410X.2004.05153.X</pub-id><pub-id pub-id-type="pmid">15610100</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Pietrzak P, Corbishley C, Watkin N. Organ-sparing surgery for invasive penile cancer: early follow-up data. BJU Int. 2004;94:1253&#8211;7. 10.1111/J.1464-410X.2004.05153.X.<pub-id pub-id-type="pmid">15610100</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1464-410X.2004.05153.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Romero</surname><given-names>FR</given-names></name><name name-style="western"><surname>Richter Pereira Dos Santos Romero</surname><given-names>K</given-names></name><name name-style="western"><surname>De Mattos</surname><given-names>MAE</given-names></name><name name-style="western"><surname>Camargo Garcia</surname><given-names>CR</given-names></name><name name-style="western"><surname>De Carvalho Fernandes</surname><given-names>R</given-names></name><name name-style="western"><surname>Cardenuto Perez</surname><given-names>MD</given-names></name></person-group><article-title>Sexual function after partial penectomy for penile cancer</article-title><source>Urology</source><year>2005</year><volume>66</volume><fpage>1292</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/J.UROLOGY.2005.06.081</pub-id><pub-id pub-id-type="pmid">16360459</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Romero FR, Richter Pereira Dos Santos Romero K, De Mattos MAE, Camargo Garcia CR, De Carvalho Fernandes R, Cardenuto Perez MD. Sexual function after partial penectomy for penile cancer. Urology. 2005;66:1292&#8211;5. 10.1016/J.UROLOGY.2005.06.081.<pub-id pub-id-type="pmid">16360459</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.urology.2005.06.081</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shkolyar</surname><given-names>E</given-names></name><name name-style="western"><surname>Laurie</surname><given-names>MA</given-names></name><name name-style="western"><surname>Mach</surname><given-names>KE</given-names></name><name name-style="western"><surname>Trivedi</surname><given-names>DR</given-names></name><name name-style="western"><surname>Zlatev</surname><given-names>DV</given-names></name><name name-style="western"><surname>Chang</surname><given-names>TC</given-names></name><etal/></person-group><article-title>Optical biopsy of penile cancer with in vivo confocal laser endomicroscopy</article-title><source>Urol Oncol</source><year>2019</year><volume>37</volume><fpage>809.e1</fpage><lpage>e8</lpage><pub-id pub-id-type="doi">10.1016/J.UROLONC.2019.08.018</pub-id><pub-id pub-id-type="pmid">31537485</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Shkolyar E, Laurie MA, Mach KE, Trivedi DR, Zlatev DV, Chang TC, et al. Optical biopsy of penile cancer with in vivo confocal laser endomicroscopy. Urol Oncol. 2019;37:809.e1&#8211;e8. 10.1016/J.UROLONC.2019.08.018.<pub-id pub-id-type="pmid">31537485</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.urolonc.2019.08.018</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>